维普中文期刊产品整合服务
15篇 您的检索式:作者名="MILANI T L"
    题名 作者 年代 出处 被引量
1Dynamic Plantar Pressure Dis-tribufion Measurements in Hemiparetic Patiens显示文摘Meyring S Diehl R R Milani T L 1997Clin Bio-mech1997,12,:1
2In-Shoe Pressure Distribution for Running in Various Types of Footwear显示文摘HENNIG E M MILANI T L 0,,03:1
3Efficacy of an acidic vaginal gel on vaginal pH and interleukin-6 levels in low-risk pregnant women: a double- blind, randomized placebo-controlled trial 显示文摘Patemoster DM Tudor L Milani M Maggino T Ambrosi- ni A 2004J Matern Fetal Neonatal Med2004,15,3:1
4In-Shoe Pressure Distribution for Running in Various Types of Footwear显示文摘Hennig E M Milani T L 1995Jonrnal of Applied Biomechanics1995,,3:1
5Regulation of autophagy by ATF4 in response to severe hypoxia 显示文摘Rzymski T Milani M Pike L 2010Oncogene2010,29,:1
6Development of a standard set of microsatellite reference alleles for identification of grape cultivars显示文摘THIS P JUNG A BOCCACCI P BORREGO J BOTTA R COSTAN-TINI L CRESPAN M DANGL G S EISENHELDC FERREIRAMONTEIRO F GRANDO S IB(A)(N)EZ J LACOMBE T LAUCOU V MAGALH(A)ES R MEREDITH C P MILANI N PETERLUNGER E REGNER F ZULINI L MAUL E 2004Theor Appl Genet2004,109,:1
7Regulation of autophagy by ATF4in response to severe hypoxia显示文摘Rzymski T Milani M Pike L 2010Oncogene2010,29,:1
8Analysis of pressure distribution for the evaluation of gait in patients with Hallux valgus surgery 显示文摘Milani T L Retzlaff S 1995Z Orthop Ihre Grenzgeb1995,133,:1
9Regulation of autophagy by ATF4 in response to severe hypoxia 显示文摘Rzymski T Milani M Pike L 2010Oncogene2010,,31:1
10Actual and perceived running performance in soccer shoes: a series of eight studies显示文摘STERZING T MULLER C HENNIG E M AND MILANI T L 2009Footwear Sci2009,1,1:1
11Traction on artifi- cial turf: development of a soccer shoe outsole显示文摘STERZING T MULEER C MILANI T L 2010Footwear Sci2010,2,1:1
12Regulation of autophagy by ATF4 in response to severe hypoxia显示文摘Rzymski T Milani M Pike L 0,,31:1
13Biomechanical re-quirements of soccer shoe construction显示文摘STERZING T HENNIG E M MILANI T L 2007Orthopa Die Tech- nik2007,,9:1
14DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia显示文摘Milani L Lundmark A Kiialainen A Nordlund J Flaegstad T Forestier E 2010Blood2010,115,6:1
15Oncologic aspects of the decision-making process for surgical approach for colorectal liver metastases progressing during chemotherapy显示文摘Colorectal cancer represents the third most diagnosed malignancy in the world.The liver is the main site of metastatic disease,affected in 30%of patients with newly diagnosed disease.Complete resection is considered the only potentially curative treatment for colorectal liver metastasis(CRLM),with a 5-year survival rate ranging from 35%to 58%.However,up to 80%of patients have initially unresectable disease,due to extrahepatic disease or bilobar multiple liver nodules.The availability of increasingly effective systemic chemotherapy has contributed to converting patients with initially unresectable liver metastases to resectable disease,improving long-term outcomes,and accessing tumor biology.In recent years,response to preoperative systemic chemotherapy before liver resection has been established as a major prognostic factor.Some studies have demonstrated that patients with regression of hepatic metastases while on chemotherapy have improved outcomes when compared to patients with stabilization or progression of the disease.Even if disease progression during chemotherapy represents an independent negative prognostic factor,some patients may still benefit from surgery,given the role of this modality as the main treatment with curative intent for patients with CRLM.In selected cases,based on size,the number of lesions,and tumor markers,surgery may be offered despite the less favorable prognosis and as an option for non-chemo responders.Raphael L C Araujo Camila G C Y Carvalho Carlos T Maeda Jean Michel Milani Diogo G Bugano Pedro Henrique Z de Moraes Marcelo M Linhares 2022World Journal of Gastrointestinal Surgery2022,14,9:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费